Search

everythinglearnresearchcommunity

for

Search:↓

DAVID syndrome is a condition with immune system and hormone deficiencies, needing early diagnosis to avoid serious complications.

Current treatments for Alopecia Areata have mixed success, and there's a need for better, more accessible options and support for affected individuals.

Steroid treatment improved both gut and nerve symptoms in a man with Cronkhite–Canada syndrome.

Alopecia Areata affects people of all ages worldwide, is likely caused by genetic and environmental factors, and can lead to stress and depression, highlighting the need for treatments that address both physical and mental health.

Modern skin cancer treatments can cause skin side effects and hair loss, affecting patients' quality of life.

Treg cell-based therapies might help treat hair loss from alopecia areata, but more research is needed to confirm safety and effectiveness.

Scientists are still unsure what triggers the immune system to attack hair follicles in Alopecia areata.

No single ideal JAK inhibitor for alopecia areata has been determined; JAK3 inhibitors may be promising with fewer side effects.

Certain immune molecules and stress affect hair loss, and while genes play a role, more research is needed to fully understand and treat it.

Most children with childhood-onset lupus in Baghdad responded well to treatment, but some developed chronic kidney disease or died.

Microneedles are a promising method for drug delivery, offering efficient and convenient alternatives with fewer side effects.

The new aptamer TAGX-0003 shows promise as an effective treatment for hair loss disorder alopecia areata.

Alopecia Areata patients have too many Firmicutes and too few Bacteroides in their gut.

Oral lichen planus is a chronic disease causing mouth discomfort and sometimes needs immunosuppressive treatment.

Alopecia areata is unpredictable, with limited treatment effectiveness, especially in severe cases.

Topical immunotherapy can treat alopecia areata, but its effectiveness varies and the exact mechanism is unclear.

New imaging tools help doctors better examine hair and scalp health without surgery.

Men and women respond differently to drugs for COVID-19, high cholesterol, and diabetes, which suggests a need for personalized treatments.

Blocking JAK1 or JAK3 helps reverse hair loss in a mouse model of alopecia areata.

Certain KIR genes in Indian SLE patients are linked to disease severity and could be biomarkers.

The study found that steroids and tetracycline helped treat active Lichen planopilaris, and hair transplants were good for later stages.

Loss of OGG1 increases skin inflammation and auto-antibodies in lupus.

PPARγ is crucial for skin health but can have both beneficial and harmful effects.

TLR4 is important in aging-related diseases and could be a new treatment target.

The workshop discussed the role of a protein called calreticulin in health and disease, its potential as a treatment target, and its possible use as a disease marker.

Early treatment of Lupus Erythematosus Alopecia can prevent permanent hair loss, and various medications are effective.

A microneedle patch can help regrow hair by restoring immune balance in hair follicles.

Stem cells and their secretions could potentially treat stress-induced hair loss, but more human trials are needed.

Further research is needed to understand how the microbiome affects hair loss in Alopecia Areata.

A patient with a nerve disorder died from infection complications after developing insulin resistance from a treatment.